Franklin Resources’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $129M | Buy |
1,623,377
+48,354
| +3% | +$3.64M | 0.03% | 402 |
|
|
2026
Q1 | $118M | Buy |
1,575,023
+253,678
| +19% | +$20M | 0.03% | 394 |
|
|
2025
Q4 | $105M | Buy |
1,321,345
+1,314,752
| +19,942% | +$99M | 0.03% | 424 |
|
|
2025
Q3 | $431K | Buy |
6,593
+1,037
| +19% | +$50.6K | ﹤0.01% | 2507 |
|
|
2025
Q2 | $220K | Buy |
+5,556
| New | +$182K | ﹤0.01% | 2712 |
|
|
2025
Q1 | – | Sell |
-13,301
| Closed | -$465K | – | 3025 |
|
|
2024
Q4 | $465K | Buy |
13,301
+3,146
| +31% | +$118K | ﹤0.01% | 2318 |
|
|
2024
Q3 | $392K | Buy |
10,155
+133
| +1% | +$6.19K | ﹤0.01% | 2386 |
|
|
2024
Q2 | $478K | Buy |
10,022
+213
| +2% | +$8.74K | ﹤0.01% | 2247 |
|
|
2024
Q1 | $425K | Sell |
9,809
-3,896
| -28% | -$186K | ﹤0.01% | 2327 |
|
|
2023
Q4 | $693K | Buy |
13,705
+5,256
| +62% | +$252K | ﹤0.01% | 1797 |
|
|
2023
Q3 | $383K | Sell |
8,449
-722
| -8% | -$29.8K | ﹤0.01% | 2044 |
|
|
2023
Q2 | $376K | Sell |
9,171
-1,229
| -12% | -$47.2K | ﹤0.01% | 2112 |
|
|
2023
Q1 | $372K | Sell |
10,400
-3,319
| -24% | -$125K | ﹤0.01% | 1786 |
|
|
2022
Q4 | $518K | Buy |
13,719
+2,468
| +22% | +$104K | ﹤0.01% | 1693 |
|
|
2022
Q3 | $497K | Buy |
+11,251
| New | +$474K | ﹤0.01% | 1687 |
|
|
2021
Q1 | – | Sell |
-3,682
| Closed | -$208K | – | 2003 |
|
|
2020
Q4 | $208K | Sell |
3,682
-238,669
| -98% | -$11.9M | ﹤0.01% | 1720 |
|
|
2020
Q3 | $11.5M | Buy |
242,351
+2,121
| +0.9% | +$118K | 0.01% | 876 |
|
|
2020
Q2 | $14.6M | Sell |
240,230
-443
| -0.2% | -$24.6K | 0.01% | 807 |
|
|
2020
Q1 | $11.4M | Sell |
240,673
-22,927
| -9% | -$1.28M | 0.01% | 785 |
|
|
2019
Q4 | $15.9M | Hold |
263,600
| – | – | 0.01% | 808 |
|
|
2019
Q3 | $15.8M | Hold |
263,600
| – | – | 0.01% | 792 |
|
|
2019
Q2 | $16.9M | Sell |
263,600
-154,400
| -37% | -$10.9M | 0.01% | 782 |
|
|
2019
Q1 | $33.9M | Buy |
418,000
+268,820
| +180% | +$17.3M | 0.02% | 615 |
|
|
2018
Q4 | $8.06M | Sell |
149,180
-341,394
| -70% | -$17.4M | ﹤0.01% | 910 |
|
|
2018
Q3 | $25.3M | Sell |
490,574
-226,442
| -32% | -$10.6M | 0.01% | 711 |
|
|
2018
Q2 | $29.9M | Sell |
717,016
-22,740
| -3% | -$1.01M | 0.02% | 665 |
|
|
2018
Q1 | $32.6M | Sell |
739,756
-10,910
| -1% | -$554K | 0.02% | 653 |
|
|
2017
Q4 | $37.8M | Sell |
750,666
-176,302
| -19% | -$9.67M | 0.02% | 607 |
|
|
2017
Q3 | $47M | Sell |
926,968
-87,096
| -9% | -$4.56M | 0.02% | 551 |
|
|
2017
Q2 | $51.6M | Sell |
1,014,064
-55,970
| -5% | -$2.61M | 0.03% | 523 |
|
|
2017
Q1 | $43M | Sell |
1,070,034
-6,500
| -0.6% | -$292K | 0.02% | 565 |
|
|
2016
Q4 | $51.6M | Buy |
1,076,534
+26,820
| +3% | +$1.06M | 0.03% | 509 |
|
|
2016
Q3 | $38.5M | Sell |
1,049,714
-34,653
| -3% | -$1.08M | 0.02% | 606 |
|
|
2016
Q2 | $25.3M | Sell |
1,084,367
-687,080
| -39% | -$22.2M | 0.01% | 740 |
|
|
2016
Q1 | $71.7M | Sell |
1,771,447
-20,300
| -1% | -$825K | 0.04% | 430 |
|
|
2015
Q4 | $111M | Sell |
1,791,747
-180,707
| -9% | -$9.75M | 0.06% | 332 |
|
|
2015
Q3 | $79.7M | Buy |
1,972,454
+2,471
| +0.1% | +$128K | 0.04% | 416 |
|
|
2015
Q2 | $113M | Buy |
1,969,983
+240,325
| +14% | +$15.3M | 0.05% | 357 |
|
|
2015
Q1 | $110M | Sell |
1,729,658
-338,291
| -16% | -$23M | 0.05% | 365 |
|
|
2014
Q4 | $128M | Sell |
2,067,949
-16,018
| -0.8% | -$790K | 0.06% | 318 |
|
|
2014
Q3 | $80.9M | Buy |
2,083,967
+132,449
| +7% | +$4.69M | 0.04% | 434 |
|
|
2014
Q2 | $67.2M | Sell |
1,951,518
-158,465
| -8% | -$4.99M | 0.03% | 502 |
|
|
2014
Q1 | $91.2M | Buy |
2,109,983
+373,329
| +21% | +$18.1M | 0.04% | 398 |
|
|
2013
Q4 | $69.2M | Sell |
1,736,654
-218,926
| -11% | -$7.8M | 0.03% | 468 |
|
|
2013
Q3 | $73.4M | Buy |
1,955,580
+124,240
| +7% | +$3.71M | 0.04% | 442 |
|
|
2013
Q2 | $49.2M | Buy |
+1,831,340
| New | +$38.9M | 0.03% | 524 |
|
Other funds holding IONS
Franklin Resources's IONS Position: Q2 2026 in Review
Franklin Resources increased its Ionis Pharmaceuticals (IONS) stake by 3.1% in Q2 2026, buying an estimated $3.64M and bringing the position to 1,623,377 shares worth $129M. The position accounts for 0.03% of the portfolio, ranked #402.
Franklin Resources first reported a position in IONS in Q2 2013 and has held it in 46 quarters since. 513 funds tracked by Wall St. Rank hold IONS as of Q2 2026.
- Franklin Resources held 1,623,377 shares of Ionis Pharmaceuticals worth $129M as of Q2 2026.
- Franklin Resources bought 48,354 Ionis Pharmaceuticals shares in Q2 2026, an estimated $3.64M.
- Ionis Pharmaceuticals made up 0.03% of Franklin Resources's portfolio in Q2 2026, its #402 holding.
- Franklin Resources first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 46 quarters since.
- 513 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.
Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.